Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea

N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and BNP measurement could have a significant role in differentiating dyspnea between cardiac or pulmonary origin in the emergency room. The development of new and different commercial assays for these B‐type natriuretic peptides offers the possibi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of clinical laboratory analysis 2006, Vol.20 (6), p.227-232
Hauptverfasser: Sanz, M.P., Borque, L., Rus, A., Vicente, B., Ramírez, Y., Lasa, L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 232
container_issue 6
container_start_page 227
container_title Journal of clinical laboratory analysis
container_volume 20
creator Sanz, M.P.
Borque, L.
Rus, A.
Vicente, B.
Ramírez, Y.
Lasa, L.
description N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and BNP measurement could have a significant role in differentiating dyspnea between cardiac or pulmonary origin in the emergency room. The development of new and different commercial assays for these B‐type natriuretic peptides offers the possibility of improving and simplifying their measurements but this could be defaulted due to the differences in methodology and the lack of assay standardization. We compared four available methods of measuring NT‐proBNP and BNP and evaluated their usefulness in diagnosing the causes of breathlessness in the emergency room. The correlation of BNP with different assays was strong with r>0.98 (P0.87. The area under the receiver‐operating characteristic curve (ROC) for BNP or NT‐proBNP for detecting any cardiac dysfunction was higher than 0.96 (95% CI). A BNP value of 116 pg/mL measurement with the Access BNP assay (Beckman Coulter Inc., Fullerton, CA), a BNP value of 79 pg/mL with Advia Centaur BNP assay (Bayer Diagnostics, Tarrytown, NY), and an NT‐proBNP level of 817 pg/mL in Elecsys NT‐proBNP assay (Roche Diagnostic, Mannheim, Germany), showed both high sensitivity (>92%) and high specificity (>93%). We have found that NT‐proBNP and BNP present similar diagnostic accuracies for the differential diagnosis of dyspnea. J. Clin. Lab. Anal. 20:227–232, 2006. © 2006 Wiley‐Liss, Inc.
doi_str_mv 10.1002/jcla.20146
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6807455</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68178963</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5226-7f2d889fd7ce926d0e36330c24159cbe71fc89a282c150a3754501f5636bfab73</originalsourceid><addsrcrecordid>eNp9kUtv1DAURi1ERacDG34A8ooFUlrbiR_ZIHUiWlpGA0hFXVqOczPjksTBzgD592QeFNiwsq597vG1P4ReUnJOCWEXD7Yx54zQTDxBM0pylTDF-FM0I0rJRBGanqKzGB8IISqn4hk6pZJSnjEyQ2Xh294EF32HfY0Xq0_YdBVe3SV98PsqRjNG7Do8bACbfto2doMHv6-hhbCGzo64cmbd-ejiTmPsdgBcjbHvwDxHJ7VpIrw4rnP05erdXfE-WX68vikul4nljIlE1qxSKq8raSFnoiKQijQllmWU57YESWurcjM9zVJOTCp5xgmtuUhFWZtSpnP09uDtt2ULlYVuCKbRfXCtCaP2xul_Tzq30Wv_XQtFZMb5JHh9FAT_bQtx0K2LFprGdOC3ceKoVPk01By9OYA2-BgD1I-XUKJ3kehdJHofyQS_-nusP-gxgwmgB-CHa2D8j0rfFsvL39Lk0OPiAD8fe0z4qoWcvkbfr651cf_hc5EVC71IfwGCO6Yw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68178963</pqid></control><display><type>article</type><title>Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea</title><source>MEDLINE</source><source>Wiley Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Sanz, M.P. ; Borque, L. ; Rus, A. ; Vicente, B. ; Ramírez, Y. ; Lasa, L.</creator><creatorcontrib>Sanz, M.P. ; Borque, L. ; Rus, A. ; Vicente, B. ; Ramírez, Y. ; Lasa, L.</creatorcontrib><description>N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and BNP measurement could have a significant role in differentiating dyspnea between cardiac or pulmonary origin in the emergency room. The development of new and different commercial assays for these B‐type natriuretic peptides offers the possibility of improving and simplifying their measurements but this could be defaulted due to the differences in methodology and the lack of assay standardization. We compared four available methods of measuring NT‐proBNP and BNP and evaluated their usefulness in diagnosing the causes of breathlessness in the emergency room. The correlation of BNP with different assays was strong with r&gt;0.98 (P&lt;0.0001). Comparison studiesbetween NT‐proBNP and BNP procedureswere in good agreement with r&gt;0.87. The area under the receiver‐operating characteristic curve (ROC) for BNP or NT‐proBNP for detecting any cardiac dysfunction was higher than 0.96 (95% CI). A BNP value of 116 pg/mL measurement with the Access BNP assay (Beckman Coulter Inc., Fullerton, CA), a BNP value of 79 pg/mL with Advia Centaur BNP assay (Bayer Diagnostics, Tarrytown, NY), and an NT‐proBNP level of 817 pg/mL in Elecsys NT‐proBNP assay (Roche Diagnostic, Mannheim, Germany), showed both high sensitivity (&gt;92%) and high specificity (&gt;93%). We have found that NT‐proBNP and BNP present similar diagnostic accuracies for the differential diagnosis of dyspnea. J. Clin. Lab. Anal. 20:227–232, 2006. © 2006 Wiley‐Liss, Inc.</description><identifier>ISSN: 0887-8013</identifier><identifier>EISSN: 1098-2825</identifier><identifier>DOI: 10.1002/jcla.20146</identifier><identifier>PMID: 17115420</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Aged ; Blood Chemical Analysis - methods ; Blood Chemical Analysis - statistics &amp; numerical data ; brain natriuretic peptides ; Case-Control Studies ; Diagnosis, Differential ; dyspnea ; Dyspnea - blood ; Dyspnea - diagnosis ; Dyspnea - etiology ; Emergency Medical Services ; Female ; heart failure ; Heart Failure - blood ; Heart Failure - complications ; Heart Failure - diagnosis ; Humans ; Immunoassay - methods ; Immunoassay - statistics &amp; numerical data ; Male ; Middle Aged ; Natriuretic Peptide, Brain - blood ; Original ; Peptide Fragments - blood ; Prospective Studies ; respiratory disease method comparison ; Respiratory Tract Diseases - blood ; Respiratory Tract Diseases - complications ; Respiratory Tract Diseases - diagnosis ; Sensitivity and Specificity</subject><ispartof>Journal of clinical laboratory analysis, 2006, Vol.20 (6), p.227-232</ispartof><rights>2006 Wiley‐Liss, Inc.</rights><rights>(c) 2006 Wiley-Liss, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5226-7f2d889fd7ce926d0e36330c24159cbe71fc89a282c150a3754501f5636bfab73</citedby><cites>FETCH-LOGICAL-c5226-7f2d889fd7ce926d0e36330c24159cbe71fc89a282c150a3754501f5636bfab73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807455/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807455/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,1417,4024,27923,27924,27925,45574,45575,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17115420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sanz, M.P.</creatorcontrib><creatorcontrib>Borque, L.</creatorcontrib><creatorcontrib>Rus, A.</creatorcontrib><creatorcontrib>Vicente, B.</creatorcontrib><creatorcontrib>Ramírez, Y.</creatorcontrib><creatorcontrib>Lasa, L.</creatorcontrib><title>Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea</title><title>Journal of clinical laboratory analysis</title><addtitle>J. Clin. Lab. Anal</addtitle><description>N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and BNP measurement could have a significant role in differentiating dyspnea between cardiac or pulmonary origin in the emergency room. The development of new and different commercial assays for these B‐type natriuretic peptides offers the possibility of improving and simplifying their measurements but this could be defaulted due to the differences in methodology and the lack of assay standardization. We compared four available methods of measuring NT‐proBNP and BNP and evaluated their usefulness in diagnosing the causes of breathlessness in the emergency room. The correlation of BNP with different assays was strong with r&gt;0.98 (P&lt;0.0001). Comparison studiesbetween NT‐proBNP and BNP procedureswere in good agreement with r&gt;0.87. The area under the receiver‐operating characteristic curve (ROC) for BNP or NT‐proBNP for detecting any cardiac dysfunction was higher than 0.96 (95% CI). A BNP value of 116 pg/mL measurement with the Access BNP assay (Beckman Coulter Inc., Fullerton, CA), a BNP value of 79 pg/mL with Advia Centaur BNP assay (Bayer Diagnostics, Tarrytown, NY), and an NT‐proBNP level of 817 pg/mL in Elecsys NT‐proBNP assay (Roche Diagnostic, Mannheim, Germany), showed both high sensitivity (&gt;92%) and high specificity (&gt;93%). We have found that NT‐proBNP and BNP present similar diagnostic accuracies for the differential diagnosis of dyspnea. J. Clin. Lab. Anal. 20:227–232, 2006. © 2006 Wiley‐Liss, Inc.</description><subject>Aged</subject><subject>Blood Chemical Analysis - methods</subject><subject>Blood Chemical Analysis - statistics &amp; numerical data</subject><subject>brain natriuretic peptides</subject><subject>Case-Control Studies</subject><subject>Diagnosis, Differential</subject><subject>dyspnea</subject><subject>Dyspnea - blood</subject><subject>Dyspnea - diagnosis</subject><subject>Dyspnea - etiology</subject><subject>Emergency Medical Services</subject><subject>Female</subject><subject>heart failure</subject><subject>Heart Failure - blood</subject><subject>Heart Failure - complications</subject><subject>Heart Failure - diagnosis</subject><subject>Humans</subject><subject>Immunoassay - methods</subject><subject>Immunoassay - statistics &amp; numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Natriuretic Peptide, Brain - blood</subject><subject>Original</subject><subject>Peptide Fragments - blood</subject><subject>Prospective Studies</subject><subject>respiratory disease method comparison</subject><subject>Respiratory Tract Diseases - blood</subject><subject>Respiratory Tract Diseases - complications</subject><subject>Respiratory Tract Diseases - diagnosis</subject><subject>Sensitivity and Specificity</subject><issn>0887-8013</issn><issn>1098-2825</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAURi1ERacDG34A8ooFUlrbiR_ZIHUiWlpGA0hFXVqOczPjksTBzgD592QeFNiwsq597vG1P4ReUnJOCWEXD7Yx54zQTDxBM0pylTDF-FM0I0rJRBGanqKzGB8IISqn4hk6pZJSnjEyQ2Xh294EF32HfY0Xq0_YdBVe3SV98PsqRjNG7Do8bACbfto2doMHv6-hhbCGzo64cmbd-ejiTmPsdgBcjbHvwDxHJ7VpIrw4rnP05erdXfE-WX68vikul4nljIlE1qxSKq8raSFnoiKQijQllmWU57YESWurcjM9zVJOTCp5xgmtuUhFWZtSpnP09uDtt2ULlYVuCKbRfXCtCaP2xul_Tzq30Wv_XQtFZMb5JHh9FAT_bQtx0K2LFprGdOC3ceKoVPk01By9OYA2-BgD1I-XUKJ3kehdJHofyQS_-nusP-gxgwmgB-CHa2D8j0rfFsvL39Lk0OPiAD8fe0z4qoWcvkbfr651cf_hc5EVC71IfwGCO6Yw</recordid><startdate>2006</startdate><enddate>2006</enddate><creator>Sanz, M.P.</creator><creator>Borque, L.</creator><creator>Rus, A.</creator><creator>Vicente, B.</creator><creator>Ramírez, Y.</creator><creator>Lasa, L.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>2006</creationdate><title>Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea</title><author>Sanz, M.P. ; Borque, L. ; Rus, A. ; Vicente, B. ; Ramírez, Y. ; Lasa, L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5226-7f2d889fd7ce926d0e36330c24159cbe71fc89a282c150a3754501f5636bfab73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Aged</topic><topic>Blood Chemical Analysis - methods</topic><topic>Blood Chemical Analysis - statistics &amp; numerical data</topic><topic>brain natriuretic peptides</topic><topic>Case-Control Studies</topic><topic>Diagnosis, Differential</topic><topic>dyspnea</topic><topic>Dyspnea - blood</topic><topic>Dyspnea - diagnosis</topic><topic>Dyspnea - etiology</topic><topic>Emergency Medical Services</topic><topic>Female</topic><topic>heart failure</topic><topic>Heart Failure - blood</topic><topic>Heart Failure - complications</topic><topic>Heart Failure - diagnosis</topic><topic>Humans</topic><topic>Immunoassay - methods</topic><topic>Immunoassay - statistics &amp; numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Natriuretic Peptide, Brain - blood</topic><topic>Original</topic><topic>Peptide Fragments - blood</topic><topic>Prospective Studies</topic><topic>respiratory disease method comparison</topic><topic>Respiratory Tract Diseases - blood</topic><topic>Respiratory Tract Diseases - complications</topic><topic>Respiratory Tract Diseases - diagnosis</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sanz, M.P.</creatorcontrib><creatorcontrib>Borque, L.</creatorcontrib><creatorcontrib>Rus, A.</creatorcontrib><creatorcontrib>Vicente, B.</creatorcontrib><creatorcontrib>Ramírez, Y.</creatorcontrib><creatorcontrib>Lasa, L.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of clinical laboratory analysis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sanz, M.P.</au><au>Borque, L.</au><au>Rus, A.</au><au>Vicente, B.</au><au>Ramírez, Y.</au><au>Lasa, L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea</atitle><jtitle>Journal of clinical laboratory analysis</jtitle><addtitle>J. Clin. Lab. Anal</addtitle><date>2006</date><risdate>2006</risdate><volume>20</volume><issue>6</issue><spage>227</spage><epage>232</epage><pages>227-232</pages><issn>0887-8013</issn><eissn>1098-2825</eissn><abstract>N‐terminal pro‐brain natriuretic peptide (NT‐proBNP) and BNP measurement could have a significant role in differentiating dyspnea between cardiac or pulmonary origin in the emergency room. The development of new and different commercial assays for these B‐type natriuretic peptides offers the possibility of improving and simplifying their measurements but this could be defaulted due to the differences in methodology and the lack of assay standardization. We compared four available methods of measuring NT‐proBNP and BNP and evaluated their usefulness in diagnosing the causes of breathlessness in the emergency room. The correlation of BNP with different assays was strong with r&gt;0.98 (P&lt;0.0001). Comparison studiesbetween NT‐proBNP and BNP procedureswere in good agreement with r&gt;0.87. The area under the receiver‐operating characteristic curve (ROC) for BNP or NT‐proBNP for detecting any cardiac dysfunction was higher than 0.96 (95% CI). A BNP value of 116 pg/mL measurement with the Access BNP assay (Beckman Coulter Inc., Fullerton, CA), a BNP value of 79 pg/mL with Advia Centaur BNP assay (Bayer Diagnostics, Tarrytown, NY), and an NT‐proBNP level of 817 pg/mL in Elecsys NT‐proBNP assay (Roche Diagnostic, Mannheim, Germany), showed both high sensitivity (&gt;92%) and high specificity (&gt;93%). We have found that NT‐proBNP and BNP present similar diagnostic accuracies for the differential diagnosis of dyspnea. J. Clin. Lab. Anal. 20:227–232, 2006. © 2006 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>17115420</pmid><doi>10.1002/jcla.20146</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0887-8013
ispartof Journal of clinical laboratory analysis, 2006, Vol.20 (6), p.227-232
issn 0887-8013
1098-2825
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6807455
source MEDLINE; Wiley Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Aged
Blood Chemical Analysis - methods
Blood Chemical Analysis - statistics & numerical data
brain natriuretic peptides
Case-Control Studies
Diagnosis, Differential
dyspnea
Dyspnea - blood
Dyspnea - diagnosis
Dyspnea - etiology
Emergency Medical Services
Female
heart failure
Heart Failure - blood
Heart Failure - complications
Heart Failure - diagnosis
Humans
Immunoassay - methods
Immunoassay - statistics & numerical data
Male
Middle Aged
Natriuretic Peptide, Brain - blood
Original
Peptide Fragments - blood
Prospective Studies
respiratory disease method comparison
Respiratory Tract Diseases - blood
Respiratory Tract Diseases - complications
Respiratory Tract Diseases - diagnosis
Sensitivity and Specificity
title Comparison of BNP and NT-proBNP assays in the approach to the emergency diagnosis of acute dyspnea
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T07%3A36%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Comparison%20of%20BNP%20and%20NT-proBNP%20assays%20in%20the%20approach%20to%20the%20emergency%20diagnosis%20of%20acute%20dyspnea&rft.jtitle=Journal%20of%20clinical%20laboratory%20analysis&rft.au=Sanz,%20M.P.&rft.date=2006&rft.volume=20&rft.issue=6&rft.spage=227&rft.epage=232&rft.pages=227-232&rft.issn=0887-8013&rft.eissn=1098-2825&rft_id=info:doi/10.1002/jcla.20146&rft_dat=%3Cproquest_pubme%3E68178963%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68178963&rft_id=info:pmid/17115420&rfr_iscdi=true